82 related articles for article (PubMed ID: 15945299)
1. [The role of aldosterone in the development of postinfarction fibrosis].
Cittadini A; Serpico R; Monti MG; Saccà L
Ital Heart J; 2005 May; 6 Suppl 1():43S-50S. PubMed ID: 15945299
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
Dieterich HA; Wendt C; Saborowski F
Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159
[TBL] [Abstract][Full Text] [Related]
3. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.
Neves MF; Amiri F; Virdis A; Diep QN; Schiffrin EL;
Can J Physiol Pharmacol; 2005 Nov; 83(11):999-1006. PubMed ID: 16391708
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation.
Young MJ
Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):174-80. PubMed ID: 18277151
[TBL] [Abstract][Full Text] [Related]
5. [Profibrotic effects of aldosterone].
Van Den Meiracker AH; Huizenga AT; Boomsma F
Ned Tijdschr Geneeskd; 2004 Jul; 148(31):1532-6. PubMed ID: 15366722
[TBL] [Abstract][Full Text] [Related]
6. [Aldosterone--classic and non classic effects].
Karram T; Hoffman A; Abbasi A; Abassi Z
Harefuah; 2002 Jun; 141(6):544-51, 578, 577. PubMed ID: 12119772
[TBL] [Abstract][Full Text] [Related]
7. Aldosterone receptor antagonism in heart failure.
Jennings DL; Kalus JS; O'Dell KM
Pharmacotherapy; 2005 Aug; 25(8):1126-33. PubMed ID: 16207104
[TBL] [Abstract][Full Text] [Related]
8. Blockades of angiotensin and aldosterone reduce osteopontin expression and interstitial fibrosis infiltration in rats with myocardial infarction.
Zhang YL; Zhou SX; Lei J; Yuan GY; Wang JF
Chin Med J (Engl); 2008 Nov; 121(21):2192-6. PubMed ID: 19080183
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone blockade over and above ACE-inhibitors in patients with coronary artery disease but without heart failure.
Shah NC; Pringle S; Struthers A
J Renin Angiotensin Aldosterone Syst; 2006 Mar; 7(1):20-30. PubMed ID: 17083070
[TBL] [Abstract][Full Text] [Related]
10. [Aldosterone blockade in essential hypertension].
Venco A; Grandi AM
Ital Heart J; 2005 May; 6 Suppl 1():34S-42S. PubMed ID: 15945298
[TBL] [Abstract][Full Text] [Related]
11. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
12. Spironolactone has antiarrhythmic activity in ischaemic cardiac patients without cardiac failure.
Shah NC; Pringle SD; Donnan PT; Struthers AD
J Hypertens; 2007 Nov; 25(11):2345-51. PubMed ID: 17921831
[TBL] [Abstract][Full Text] [Related]
13. Expression of procollagen C-proteinase enhancer-1 in the remodeling rat heart is stimulated by aldosterone.
Kessler-Icekson G; Schlesinger H; Freimann S; Kessler E
Int J Biochem Cell Biol; 2006 Mar; 38(3):358-65. PubMed ID: 16300990
[TBL] [Abstract][Full Text] [Related]
14. Aldosterone and end-organ damage.
Marney AM; Brown NJ
Clin Sci (Lond); 2007 Sep; 113(6):267-78. PubMed ID: 17683282
[TBL] [Abstract][Full Text] [Related]
15. Central infusion of aldosterone synthase inhibitor attenuates left ventricular dysfunction and remodelling in rats after myocardial infarction.
Huang BS; White RA; Ahmad M; Tan J; Jeng AY; Leenen FH
Cardiovasc Res; 2009 Feb; 81(3):574-81. PubMed ID: 18689429
[TBL] [Abstract][Full Text] [Related]
16. [The AREA IN-CHF trial (antiremodeling effect of aldosterone receptors blockade with canrenone in mild chronic heart failure): rationale and design].
Cacciatore G; Boccanelli A; Mureddu GF; Maggioni AP; Latini R; Masson S; de Simone G;
Ital Heart J; 2005 May; 6 Suppl 1():66S-74S. PubMed ID: 15945301
[TBL] [Abstract][Full Text] [Related]
17. Neurohormones and heart failure: the importance of aldosterone.
Odedra K; Ferro A
Int J Clin Pract; 2006 Jul; 60(7):835-46. PubMed ID: 16846401
[TBL] [Abstract][Full Text] [Related]
18. Aldosterone-and-salt-induced cardiac fibrosis is independent from angiotensin II type 1a receptor signaling in mice.
Kagiyama S; Matsumura K; Fukuhara M; Sakagami K; Fujii K; Iida M
Hypertens Res; 2007 Oct; 30(10):979-89. PubMed ID: 18049031
[TBL] [Abstract][Full Text] [Related]
19. Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study.
Izawa H; Murohara T; Nagata K; Isobe S; Asano H; Amano T; Ichihara S; Kato T; Ohshima S; Murase Y; Iino S; Obata K; Noda A; Okumura K; Yokota M
Circulation; 2005 Nov; 112(19):2940-5. PubMed ID: 16275882
[TBL] [Abstract][Full Text] [Related]
20. Aldosterone, mineralocorticoid receptors, and vascular inflammation.
Fiebeler A; Muller DN; Shagdarsuren E; Luft FC
Curr Opin Nephrol Hypertens; 2007 Mar; 16(2):134-42. PubMed ID: 17293689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
